Drug Profile
Gentiopicrin
Alternative Names: Gentiopicroside; QINGLONG KUSULatest Information Update: 28 Dec 2018
Price :
$50
*
At a glance
- Originator Northwest University
- Developer Harbin Gloria Pharmaceuticals
- Class Glucosides; Glycosides; Pyrans; Pyrones
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for clinical-Phase-Unknown development in Hepatitis-B in China (IV, Injection)
- 26 Nov 2015 Clinical trials in Hepatitis B in China (IV)